Other
Neoplasm by Site
CI-CAN-00000003Explore in graph →
Non-malignant20,494 active trials253 approved drugs3,567 evidence items
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000003Explore in graph →
Clinical trials
92,594 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00645138 | Comparison of Paravertebral Block With General Anesthesia in Patients Undergoing Breast Cancer Surgery | completed | Phase 3 | 40 | Weill Medical College of Cornell UniversityOTHER | 1 | Aug 5, 2011 | clinicaltrials |
| NCT00696553 | Nutrition and Resistance Training in Head and Neck Cancer(ELAF) | completed | Phase 3 | 60 | Vanderbilt UniversityOTHER | 1 | Jul 27, 2011 | clinicaltrials |
| NCT00057720 | TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer | completed | Phase 3 | 440 | TelikINDUSTRY | 13 | Jul 25, 2011 | clinicaltrials |
| NCT00606983 | Prevention of Acute Voiding Difficulty After Radical Proctectomy | completed | Phase 3 | 100 | Seoul National University HospitalOTHER | 1 | Jul 20, 2011 | clinicaltrials |
| NCT00626431 | A Study of Leuprolide to Treat Prostate Cancer | completed | Phase 3 | 310 | AbbottINDUSTRY | 1 | Jul 19, 2011 | clinicaltrials |
| NCT00782145 | A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families | completed | Phase 3 | 198 | Tufts Medical CenterOTHER | 1 | Jul 13, 2011 | clinicaltrials |
| NCT00970138 | Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric Cancer | completed | Phase 2 / Phase 3 | 141 | Fudan UniversityOTHER | 1 | Jul 12, 2011 | clinicaltrials |
| NCT00094653 | MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma | completed | Phase 3 | 1,783 | Bristol-Myers SquibbINDUSTRY | 13 | Jul 11, 2011 | clinicaltrials |
| NCT00422890 | Treatment of Imminent Haematological Relapse in Patients With AML and MDS Following Allogeneic Stem Cell Transplantation With 5-azacitidine (Vidaza®) | completed | Phase 3 | 10 | Technische Universität DresdenOTHER | 1 | Jul 11, 2011 | clinicaltrials |
| NCT01385891 | Clove In The Treatment Of Relapsed Or Resistant Acute Leukemia In Children(CLOVE) | completed | Phase 2 / Phase 3 | 40 | Istituto Giannina GasliniOTHER | 1 | Jul 8, 2011 | clinicaltrials |
| NCT00150670 | Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric Cancer | completed | Phase 3 | 300 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00152178 | The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC) | completed | Phase 3 | 680 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00152191 | A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC) | completed | Phase 3 | 1,300 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00152217 | Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC) | completed | Phase 3 | 1,000 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00152230 | A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC) | completed | Phase 3 | 900 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00152243 | A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC) | completed | Phase 3 | 500 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00202969 | Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer | completed | Phase 3 | 180 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00186212 | Alternative Support for Rural and Isolated Women in an HMO | completed | Phase 3 | 150 | Stanford UniversityOTHER | 1 | Jul 1, 2011 | clinicaltrials |
| NCT00525096 | Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer | completed | Phase 3 | 157 | ARCAGY/ GINECO GROUPOTHER | 0 | Jun 30, 2011 | clinicaltrials |
| NCT00287768 | Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer | completed | Phase 3 | 628 | Japan Clinical Cancer Research OrganizationOTHER | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00415194 | A Study for Patients With Head and Neck Cancer | completed | Phase 3 | 795 | Eli Lilly and CompanyINDUSTRY | 21 | Jun 28, 2011 | clinicaltrials |
| NCT00546780 | A Study of Tanespimycin (KOS-953) in Patients With Multiple Myeloma in First Relapse(BMS TIME-1) | completed | Phase 3 | 31 | Bristol-Myers SquibbINDUSTRY | 2 | Jun 28, 2011 | clinicaltrials |
| NCT00639327 | Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer | completed | Phase 2 / Phase 3 | 300 | Japan Clinical Cancer Research OrganizationOTHER | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00352378 | Primary Chemotherapy With Adriamycin/Cyclophosphamide(AC) vs Taxotere/Xeloda(TX) for Stage II and III Breast Cancer | completed | Phase 3 | 209 | National Cancer Center, KoreaOTHER_GOV | 0 | Jun 27, 2011 | clinicaltrials |
| NCT00294385 | Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of Docetaxel Followed by Gemcitabine | completed | Phase 3 | 430 | Central European Cooperative Oncology GroupOTHER | 7 | Jun 23, 2011 | clinicaltrials |
| NCT00036400 | Study of the Efficacy and Safety of Epoetin Alfa Administered Weekly in Patients With Gastric or Rectal Cancers Undergoing a Treatment Plan of Preoperative Chemotherapy and Radiation Therapy, Followed by Surgery | completed | Phase 3 | 60 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 0 | Jun 10, 2011 | clinicaltrials |
| NCT00344422 | Vincristine, DOXIL (Doxorubicin HCl Liposome Injection) and Dexamethasone vs. Vincristine, Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma | completed | Phase 3 | 198 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 0 | Jun 10, 2011 | clinicaltrials |
| NCT00474006 | High Dose Daunorubicin Vs. Standard Dose Daunorubicin in Induction Treatment of AML(ADcomparison) | completed | Phase 3 | 398 | Cooperative Study Group A for HematologyNETWORK | 1 | Jun 10, 2011 | clinicaltrials |
| NCT00798447 | Efficacy and Safety of a PN Regimen Containing n-3 Fatty Acid in Patients Considered After GI Surgery | completed | Phase 3 | 100 | B. Braun Melsungen AGINDUSTRY | 1 | Jun 9, 2011 | clinicaltrials |
| NCT00076986 | The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme | completed | Phase 3 | 300 | INSYS Therapeutics IncINDUSTRY | 6 | Jun 6, 2011 | clinicaltrials |
| NCT00261677 | A Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing Chemotherapy | completed | Phase 3 | 224 | Ortho Biotech Products, L.P.INDUSTRY | 0 | May 23, 2011 | clinicaltrials |
| NCT00005648 | Gemcitabine With or Without Tipifarnib (R115777) in Treating Patients With Advanced Pancreatic Cancer | completed | Phase 3 | 688 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 0 | May 19, 2011 | clinicaltrials |
| NCT00521664 | A Trial Comparing a Prophylactic With a Therapeutic Platelet Transfusion Strategy in Two Groups | completed | Phase 3 | 400 | Technische Universität DresdenOTHER | 1 | May 19, 2011 | clinicaltrials |
| NCT00270101 | The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma | completed | Phase 3 | 156 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 0 | May 18, 2011 | clinicaltrials |
| NCT00270166 | The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy | completed | Phase 3 | 201 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 0 | May 18, 2011 | clinicaltrials |
| NCT00661999 | Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer | completed | Phase 3 | 502 | Mayo ClinicOTHER | 1 | May 17, 2011 | clinicaltrials |
| NCT00076388 | Iressa Versus Docetaxel (Taxotere) | completed | Phase 3 | 1,440 | AstraZenecaINDUSTRY | 25 | May 13, 2011 | clinicaltrials |
| NCT00381901 | Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery | completed | Phase 3 | 3,400 | National Cancer Institute, FranceOTHER_GOV | 1 | May 13, 2011 | clinicaltrials |
| NCT01014026 | Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention(APACHE-1) | completed | Phase 3 | 734 | University Hospital, ToursOTHER | 1 | May 13, 2011 | clinicaltrials |
| NCT00244309 | Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancer | completed | Phase 3 | 348 | Case Comprehensive Cancer CenterOTHER | 1 | May 4, 2011 | clinicaltrials |
| NCT00193011 | Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast Cancer | completed | Phase 3 | 150 | SCRI Development Innovations, LLCOTHER | 0 | May 3, 2011 | clinicaltrials |
| NCT00236275 | PET and MRI in the Follow-up of Neoadjuvant Chemotherapy of Breast Cancer | completed | Phase 3 | 60 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | May 2, 2011 | clinicaltrials |
| NCT00154375 | Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma | completed | Phase 3 | 240 | Novartis PharmaceuticalsINDUSTRY | 1 | Apr 26, 2011 | clinicaltrials |
| NCT00016432 | Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen | completed | Phase 3 | 1,598 | NSABP Foundation IncNETWORK | 3 | Apr 19, 2011 | clinicaltrials |
| NCT00168181 | Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer Patients | completed | Phase 3 | 220 | Alberta Health servicesOTHER | 1 | Apr 18, 2011 | clinicaltrials |
| NCT00964210 | Protecting Young Special Risk Females From Cervical Cancer Through Human Papilloma Virus (HPV) Vaccination(HPV) | completed | Phase 3 | 240 | Murdoch Childrens Research InstituteOTHER | 1 | Apr 15, 2011 | clinicaltrials |
| NCT00179621 | Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q[31] Abnormality | completed | Phase 3 | 205 | Celgene CorporationINDUSTRY | 9 | Apr 14, 2011 | clinicaltrials |
| NCT00391274 | Chemotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 211 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 12, 2011 | clinicaltrials |
| NCT00186966 | Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid Leukemia | completed | Phase 3 | 394 | Dutch Childhood Oncology GroupOTHER | 1 | Apr 6, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Aug 5, 2011source: clinicaltrials